NetworkNewsBreaks – Predictive Oncology Inc.’s

NetworkNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Recent Board Appointments Combine Deep Experience, Expertise to Drive Strategic Vision

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine, recently announced board appointments to align expertise with the company’s strategic vision. These recently appointed board members — Dr. Nancy Chung-Welch, PhD; Charles L. Nuzum, CPA; and Greg St. Clair — bring to POAI more than a century of invaluable combined experience and life-science, business-development, marketing and financial expertise. An article discussing this quotes POAI CEO Dr. Carl Schwartz, who stated, “These appointments signify our absolute commitment to aligning our board’s expertise with the company’s strategic vision of developing and commercializing an offering that will enable us to support the improvement in health-care outcomes for oncology patients and increase value to our shareholders. Each of these members brings a wealth of knowledge, experience and thought leadership that will be highly valuable as we execute our plans to develop and market AI-based predictive models that leverage our unique tumor bank.”

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer